Literature DB >> 25023043

Overall response rates to radiation therapy for patients with painful uncomplicated bone metastases undergoing initial treatment and retreatment.

Gillian Bedard1, Peter Hoskin2, Edward Chow3.   

Abstract

INTRODUCTION: Radiation therapy has been shown to successfully palliate bone metastases. A number of systematic reviews and large clinical trials have reported response rates for initial treatment and retreatment.
OBJECTIVE: To determine overall response rates of patients with painful uncomplicated bone metastases undergoing initial treatment and retreatment.
METHODS: Intent-to-treat and evaluable patient statistics from a systematic review of palliative radiotherapy trials for initial treatment of bone metastases and a randomized clinical trial of retreatment were pooled and analyzed to determine the overall response rates for patients receiving initial treatment and retreatment.
RESULTS: In the intent-to-treat calculation, 71-73% of patients had an overall response to radiation treatment and in the evaluable patient population; 85-87% of patients did so. Response rates varied slightly whether patients underwent single or multiple fractions in initial treatment or retreatment.
CONCLUSIONS: Single and multiple fraction radiation treatment yielded very similar overall response rates. Patients treated with a single fraction for both initial and repeat radiation experience almost identical overall response to those patients treated with multiple fraction treatment. It is therefore recommended that patients with uncomplicated painful bone metastases be treated with a single 8 Gy fraction of radiation at both the initial treatment and retreatment.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bone metastases; Radiation therapy; Retreatment

Mesh:

Year:  2014        PMID: 25023043     DOI: 10.1016/j.radonc.2014.06.015

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  Limited short-term effect of palliative radiation therapy on quantitative computed tomography-derived bone mineral density in femora with metastases.

Authors:  Florieke Eggermont; Loes C Derikx; Nico Verdonschot; Gerjon Hannink; Robert S J P Kaatee; Esther Tanck; Yvette M van der Linden
Journal:  Adv Radiat Oncol       Date:  2016-11-10

2.  The role of postoperative radiation and coordination of care in patients with metastatic bone disease of the appendicular skeleton.

Authors:  Andrew R Summers; Travis Philipp; Jacob D Mikula; Kenneth R Gundle
Journal:  Orthop Rev (Pavia)       Date:  2018-02-16

3.  Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance.

Authors:  Carsten Nieder; Astrid Dalhaug; Ellinor Haukland; Bård Mannsåker; Adam Pawinski
Journal:  Int J Circumpolar Health       Date:  2017       Impact factor: 1.228

4.  Do Sustainable Palliative Single Fraction Radiotherapy Practices Proliferate or Perish 2 Years after a Knowledge Translation Campaign?

Authors:  Shaheer Shahhat; Nikesh Hanumanthappa; Youn Tae Chung; James Beck; Rashmi Koul; Bashir Bashir; Andrew Cooke; Arbind Dubey; Jim Butler; Maged Nashed; William Hunter; Aldrich D Ong; Shrinivas Rathod; Kim Tran; Julian O Kim
Journal:  Curr Oncol       Date:  2022-07-19       Impact factor: 3.109

5.  Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23.

Authors:  Rachel McDonald; Keyue Ding; Michael Brundage; Ralph M Meyer; Abdenour Nabid; Pierre Chabot; Genevieve Coulombe; Shahida Ahmed; Joda Kuk; A Rashid Dar; Aamer Mahmud; Alysa Fairchild; Carolyn F Wilson; Jackson S Y Wu; Kristopher Dennis; Carlo DeAngelis; Rebecca K S Wong; Liting Zhu; Stephanie Chan; Edward Chow
Journal:  JAMA Oncol       Date:  2017-07-01       Impact factor: 31.777

6.  Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction Radiotherapy.

Authors:  Carsten Nieder; Bard Mannsaker; Astrid Dalhaug
Journal:  J Clin Med Res       Date:  2020-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.